Targeting cellular senescence as a novel treatment for osteoarthritis

Astrike-Davis, E.M., Coryell, P., &amp; Loeser, R.F. (2022). Targeting cellular senescence as a novel treatment for osteoarthritis. <em>Current Opinion in Pharmacology</em>. https://doi.org/10.1016/j.coph.2022.102213

Astrike-Davis EM, Coryell P, Loeser RF. Targeting cellular senescence as a novel treatment for osteoarthritis. Current Opinion in Pharmacology. 2022. doi:10.1016/j.coph.2022.102213.

@unpublished{emma2022Target, title = {Targeting cellular senescence as a novel treatment for osteoarthritis}, author = {Emma M. Astrike-Davis and Philip Coryell and Richard F. Loeser}, journal = {Current Opinion in Pharmacology}, year = {2022}, doi = {10.1016/j.coph.2022.102213}, }